The P&T Committee is an advisory panel who conducts in-depth clinical evaluations and recommends appropriate drugs for preferred status on DOM’s Preferred Drug List and/or drugs for prior authorization. Drugs and drug classes are evaluated for their safety, efficacy, and overall cost value and the committee will make subsequent recommendations.